CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC

Greten Tim F.; Korangy Firouzeh

首页> 外文期刊>Fortschritte der Physik >CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC

【24h】

CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC

机译：CDK20抑制和免疫检查点阻断：将癌症生物学和肿瘤免疫学结合在一起，为HCC制定新的治疗方案

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Fortschritte der Physik》 |2018年第5期|共2页
作者
Greten Tim F.; Korangy Firouzeh;
展开▼
作者单位

NCI Gastrointestinal Malignancy Sect Thorac &

Gastrointestinal Oncol Branch Ctr Canc Res NIH 9000 Rockville Pike Bethesda MD 20892 USA;

NCI Gastrointestinal Malignancy Sect Thorac &

Gastrointestinal Oncol Branch Ctr Canc Res NIH 9000 Rockville Pike Bethesda MD 20892 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类物理学;
关键词

相似文献

外文文献
中文文献
专利

1. CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC [J] . Tim F Greten, Firouzeh Korangy Gut: Journal of the British Society of Gastroenterology . 2018,第5期

机译：CDK20抑制和免疫检查点阻断：将癌症生物学和肿瘤免疫学结合在一起，为HCC制定新的治疗方案
2. Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity [J] . Sophie Langdon, Adina Hughes, Molly A. Taylor, Oncoimmunology. . 2018,第8期

机译：双MTORC1 / 2抑制和免疫检查点阻断抗肿瘤免疫的组合
3. NEOADJUVANT IMMUNE CHECKPOINT BLOCKADE FOR PANCREATIC CANCER PREVENTS LOCAL TUMOUR RECURRENCE THROUGH TISSUE RESIDENT ANTITUMOURAL CD8+CD103+T CELLS [J] . Jennifer Brooks, Bettina Fleischmann-Mundt, Norman Woller, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2015,第S1期

机译：Neoadjuvant免疫检查点阻断胰腺癌可防止局部肿瘤通过组织静脉抗核CD8 + CD103 + T细胞复发
4. Effects of EGCG and DAC Combinational Treatment on Treating Triple Negative Breast Cancer and Aiding Immune Checkpoint Blockage Therapies [D] . Wang, Zixu. 2019

机译：EGCG和DAC组合治疗对治疗三重阴性乳腺癌的影响及辅助免疫检查点梗阻疗法
5. CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC [O] . Tim F Greten, Firouzeh Korangy -1

机译：CDK20抑制和免疫检查点封锁：将癌症生物学和肿瘤免疫学结合在一起为肝癌开发新的治疗选择
6. Successful Treatment of Cytokine Release Syndrome with IL ‐6 Blockade in a Patient Transitioning from Immune‐Checkpoint to MEK / BRAF Inhibition: A Case Report and Review of Literature [O] . Adam Amlani, Claire Barber, Aurore Fifi‐Mah, 2020

机译：在从免疫检查点转移到MEK / BRAF抑制中，用IL-6阻断成分对细胞因子释放综合征的成功治疗案例报告和文学案例

CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC

著录项

相似文献

相关主题

期刊订阅